ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00517920
Recruitment Status : Completed
First Posted : August 17, 2007
Last Update Posted : January 4, 2013
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2011
  Actual Study Completion Date : June 2012
  Certification/Extension First Submitted : June 29, 2012